United States · FDA National Drug Code directory

Obagi-C C-Rx System Normal-Oily Skin Intervention

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62032-915_d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7
Product NDC: 62032-915
Form: KIT
Composition / generic term: HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE
Labeler: Obagi Cosmeceuticals LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start / end (source format): 20191202
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 KIT (62032-915-01) * 177 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 30 mL in 1 BOTTLE, GLASS (62032-122-10) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) · 62032-915-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →